Peptide antigen of pregnancy-related glycoprotein in cattle and sheep and its application

By designing polypeptide antigens and corresponding antibodies for cow and sheep pregnancy-related glycoproteins, the joint test of cattle and sheep early pregnancy was achieved, solving the problem of single species detection in the existing technology, improving user convenience and production efficiency, and demonstrating efficient detection performance.

CN117820434BActive Publication Date: 2024-11-19WUHAN UNI-SCIENCE BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311860937.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-12-31
Publication Date
2024-11-19
Estimated Expiration
2043-12-31

AI Technical Summary

Technical Problem

The prior art cannot detect early pregnancy of cattle and sheep at the same time, and the lack of colloidal gold test strips for early pregnancy test of cattle and sheep, resulting in a single species detection, which has high user convenience and production costs.

Method used

A polypeptide antigen of cow and sheep gestation-related glycoproteins was designed, including two amino acid sequences targeting cow and sheep cow, and was used to prepare labeled antibodies and coated antibodies, and applied to colloidal gold detection test strips to achieve simultaneous detection of early pregnancy of cattle and sheep.

Benefits of technology

The provided polypeptide antigen can be used to simultaneously detect early pregnancy of cattle and sheep, filling the gaps in the prior art, improving user convenience, reducing production costs, and demonstrating efficient detection performance through ELISA detection and test strip card verification.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117820434B_ABST
    Figure CN117820434B_ABST
Patent Text Reader

Abstract

The present invention discloses a polypeptide antigen of cattle and sheep pregnancy-related glycoprotein and its application. The polypeptide antigen of cattle and sheep pregnancy-related glycoprotein includes two common antigen polypeptides for cattle and sheep pregnancy-related glycoprotein, and its amino acid sequence is shown as SEQ ID No.1 and 2 respectively. The polypeptide antigen provided by the present invention is a common antigen of cattle and sheep pregnancy-related glycoprotein, and the antibody prepared with the polypeptide antigen can be used to detect cattle and sheep early pregnancy at the same time. The test paper of the present invention fills the gap of the prior art and can combine two reagent cards on the market into one reagent card, which improves the convenience of use for customers on the one hand and reduces the production cost of manufacturers on the other hand.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of antibodies, and in particular to a polypeptide antigen of a bovine and sheep pregnancy-related glycoprotein and its application. Background Art

[0002] Early pregnancy-associated glycoprotein (PAG) is currently a commonly used diagnostic indicator for early pregnancy in cattle and sheep. By measuring the concentration changes of PAG in the blood of livestock, the pregnancy status of cattle and sheep can be judged as early as possible. The prior art provides a monoclonal antibody to pregnancy-associated glycoprotein and its application in early pregnancy detection in cattle (CN 114134123A), but this technology can only detect the species of cattle, which is relatively single. The same is true for other prior art reports, which are used to detect pregnancy in a single species of cattle or sheep. According to research, there are currently no reports on colloidal gold test strips for combined early pregnancy testing in cattle and sheep on the market. Summary of the invention

[0003] In order to fill the gap in the prior art, the present invention provides a polypeptide antigen of cattle and sheep pregnancy-related glycoprotein and its application.

[0004] Specifically, the polypeptide antigen of bovine and goat pregnancy-associated glycoprotein of the present invention comprises two common antigen polypeptides for bovine and goat pregnancy-associated glycoprotein, and the amino acid sequences thereof are shown in SEQ ID No. 1 and 2, respectively.

[0005] The amino acid sequence of SEQ ID No.1 is as follows:

[0006] Phe Asp Thr Gly Ser Ser Asp Leu Leu Val Pro Ser Ile Asn

[0007] The amino acid sequence of SEQ ID No.2 is as follows:

[0008] Ser Phe Leu Lys Glu His Ala Tyr Arg Leu Ser Gln Ile Ser Phe Arg AlaSer Asn Leu

[0009] In the above scheme, the polypeptide antigen with the amino acid sequence of SEQ ID No.1 is used to prepare the labeled antibody for sandwich detection, and the polypeptide antigen with the amino acid sequence of SEQ ID No.2 is used to prepare the coated antibody for sandwich detection.

[0010] The present invention also provides a monoclonal antibody for detecting cattle and sheep pregnancy-related glycoproteins prepared by using the polypeptide antigen of the cattle and sheep pregnancy-related glycoproteins, and provides the use of the monoclonal antibody for detecting cattle and sheep pregnancy-related glycoproteins in preparing a test strip or a test kit.

[0011] The present invention also provides a test strip for detecting cattle and sheep pregnancy-related glycoproteins, the test strip comprising a sample pad, a conjugation pad, a coating membrane and a water-absorbing pad, the conjugation pad is coated with a labeled antibody prepared with the amino acid sequence of SEQ ID No.1 as a polypeptide antigen, and the coating membrane is coated with a coating antibody prepared with the amino acid sequence of SEQ ID No.2 as a polypeptide antigen.

[0012] The beneficial effects of the present invention are as follows: the provided polypeptide antigen is a common antigen of cattle and sheep pregnancy-related glycoproteins, and the antibody prepared with the polypeptide antigen can be used to simultaneously detect early pregnancy in cattle and sheep. The test strip of the present invention fills the gap in the prior art and can combine two reagent cards on the market into one reagent card, which improves the convenience of use for customers on the one hand and reduces the production cost of manufacturers on the other. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 : Schematic diagram of the structure of colloidal gold test strips.

[0014] Figure 2 : Four-parameter fitting curve diagram of labeled antibody ELISA detection.

[0015] Figure 3 : Four-parameter fitting curve diagram of coated antibody ELISA detection. DETAILED DESCRIPTION

[0016] The present invention is described in detail below in conjunction with the embodiments and drawings. The following embodiments are implemented on the premise of the technical solution of the present invention, and provide detailed implementation methods and specific operating processes, but the protection scope of the present invention is not limited to the following embodiments.

[0017] In the following examples, unless otherwise specified, all methods are conventional methods; the reagents and materials described, unless otherwise specified, can be obtained from commercial sources.

[0018] Example 1

[0019] Preparation of monoclonal antibodies against cattle and sheep pregnancy-related glycoproteins of the present invention

[0020] 1. Coupling of polypeptides with carrier proteins: The inventors of this application have redesigned the antigen polypeptide sequence of the present invention after studying existing competitive products and combining computer simulation. Peptide 1 and polypeptide 2 were obtained through artificial synthesis, and the polypeptides were coupled with carrier proteins to prepare antigen polypeptide 1-KLH (keyhole limpet hemocyanin), polypeptide 1-OVA (ovalbumin), polypeptide 2-BSA (bovine serum albumin), polypeptide 2-OVA (SMCC activated carrier protein, connecting the amino group of the protein and the thiol group on the cysteine ​​of the polypeptide through SMCC);

[0021] 2. Preparation of monoclonal antibodies: Mix polypeptide 1-KLH and polypeptide 2-BSA with adjuvants, immunize Balb / c mice 4 times, and coat them with polypeptide 1-OVA and polypeptide 2-OVA respectively to detect serum titer. If the titer is low, continue to immunize 1-2 times until the serum titer reaches 1:128000, the immunization is qualified, and cell fusion is prepared. Select the mouse with the highest titer, remove the spleen on a sterile operating table, prepare spleen cells and myeloma cells, and perform electrofusion. The fused cells are resuspended in HAT screening medium, spread on 10 96-well plates, and cultured at 37°C and 5% CO2; on the third day of fusion, use HAT screening medium for half-medium replacement, on the fifth day of fusion, use HAT screening medium for full medium replacement, and on the eighth day of fusion, aspirate 100μl supernatant from each well for detection. The detection steps are as follows:

[0022] (1) Use peptide 1-OVA and peptide 2-OVA to coat a 96-well ELISA plate in advance, add the fusion supernatant to the coated plate, 100 μl / well, and incubate at 37°C for 1 hour; (2) Discard the supernatant, wash the plate three times with detergent, and pat dry; (3) Add secondary antibody, 100 μl / well, and incubate at 37°C for 0.5 hour; (4) Discard the supernatant, wash the plate three times with detergent, and pat dry; (5) Add colorimetric solution, 100 μl / well, and incubate at 37°C in the dark for 10 minutes; (6) Add stop solution 2M HCl 50 μl / well; (7) Place in an ELISA reader and read at 450-630 nm.

[0023] According to the data, several positive wells are selected, the liquid in the corresponding numbered 96-well plate wells is discarded, and 200 μl / well HAT screening medium is added again, and cultured at 37°C and 5% CO2. The cell supernatant is aspirated the next day for re-examination. During the re-examination, a non-specific peptide-BSA coated plate is used as a negative screening to screen out clones that recognize the peptide and the carrier linker site, and only clones that are positive for the target peptide-BSA are retained. The corresponding 96-well cells are transferred to 24-wells for expansion and culture. When the cells are cultured to occupy 80% of the bottom area of ​​the well, they are frozen for seed preservation; select cells that need to be subcloned, resuscitate, use HT medium, and perform subcloning by limiting dilution method, put the subcloning plate into a 37°C, 5% CO2 incubator for about 8 days, take the cell supernatant for detection, pick the positive wells and continue subcloning until a monoclonal cell line is obtained; the monoclonal cell line is expanded and cultured, and monoclonal antibodies can be prepared by suspension culture or ascites, and the monoclonal antibodies are purified by ProG to obtain monoclonal antibodies, and the antibody concentration is detected by UV method.

[0024] Example 2

[0025] Preparation of the test paper card of the present invention

[0026] 1. Preparation of colloidal gold solution: Take a clean round-bottom flask, add double distilled water, place it on a magnetic heating stirrer, heat and stir until boiling, add 1% chloroauric acid solution to a final concentration of 1 / 10,000, and continue to heat until boiling; then add 1% trisodium citrate solution at a ratio of 1:1.6, continue to heat and boil for about 10 minutes, until the solution presents a translucent red color. After cooling to room temperature (15°C-25°C), dilute to the original planned volume with double distilled water (compensate for evaporation losses), thereby obtaining a colloidal gold solution.

[0027] 2. Preparation of colloidal gold binding pad: Place colloidal gold solution on a magnetic stirrer, adjust pH to about 8.2 with 0.2M K2CO3, add 5μg / ml PAG monoclonal antibody 1 (labeled antibody prepared from polypeptide 1) under stirring, stir at room temperature for 30 minutes; add 10% bovine serum albumin (BSA) solution to a final concentration of 1%, stir at room temperature for 30 minutes; centrifuge the solution at 4°C and 10000r / min for 30 minutes, discard the supernatant, resuspend the precipitate with a gold complex solution of 1% volume colloidal gold solution, and mix well. Use an ultraviolet spectrophotometer to test the OD value of the gold-labeled conjugate, use a gold spray film instrument to spray the gold-labeled conjugate diluted to an OD value of 1.0 on a 10mm*30cm glass cellulose membrane at a spray volume of 2μl / cm, place it in a blast drying oven at 37°C and a humidity of 10%-30% for 24 hours, and set aside.

[0028] 3. Preparation of coating membrane: Dilute goat anti-mouse IgG monoclonal antibody and PAG monoclonal antibody 2 (coating antibody prepared from polypeptide 2) to final concentrations of 0.3 mg / ml and 0.5 mg / ml respectively with coating solution, and spray them on corresponding positions of nitrocellulose membrane using a gold spray film streaking instrument at an amount of 1 μl / cm to prepare C line and T line, and place the membrane in a forced air drying oven at 37°C and a humidity of 10%-30% for 24 hours for use.

[0029] 4. Preparation of sample pad: Prepare sample pad treatment solution, evenly apply 50 ml of sample pad treatment solution on a 25cm*30cm glass cellulose membrane, place in a drying room at room temperature with a humidity of 10%-30% for 15 hours-18 hours, and set aside.

[0030] 5. Large board assembly: Cut the processed sample pad into 3.0cm*30cm specifications; the nitrocellulose membrane specifications are 2.5cm*30cm; the absorbent pad specifications are 1.7cm*30cm; the PVC base plate specifications are 6.0cm*30cm; assemble the absorbent paper, NC membrane, binding pad, and sample pad on the PVC base plate in order.

[0031] 6. Test strip card assembly: Cut the assembled large board into 3.00mm width with a strip cutter and put it into a plastic card shell. Put the assembled card shell together with the desiccant into an aluminum foil bag and seal it.

[0032] 7. Composition of colloidal gold test paper card: The test paper card consists of a test paper strip and a buckle, the buckle consists of an upper shell and a lower shell; the test paper strip (see Figure 1 ) includes a PVC base plate, a nitrocellulose membrane, a water absorbent pad, a colloidal gold binding pad, and a sample pad. The colloidal gold binding pad is coated with a PAG monoclonal antibody-colloidal gold marker, and the nitrocellulose membrane is coated with a quality control line C line composed of a goat anti-mouse IgG monoclonal antibody and a detection line T line composed of a PAG monoclonal antibody.

[0033] Test example

[0034] 1. Antigen-antibody affinity data

[0035] According to the saturation concentration method, when using ELISA for affinity determination, an obvious four-parameter S-shaped curve is required, that is, a signal curve that changes gradually with the antibody concentration is required. There are obvious upper and lower plateaus at low and high antibody concentrations. The antibody concentration (EC50) value corresponding to half of the upper plateau signal value is the affinity KD value between the antigen and antibody. The main test steps are as follows:

[0036] (1) Preparation of ELISA plate: Dissolve the peptide 1-OVA antigen and the peptide 2-OVA antigen at room temperature, mix well, dilute to 1 μg / ml with coating solution, 100 μl / well, add to 96-well ELISA plate, and incubate at 2-8°C overnight;

[0037] (2) Wash the plate three times with washing solution, pat dry, add 300 μl / well blocking solution, and block at room temperature for 1 hour; wash the plate three times with washing solution, pat dry and set aside;

[0038] (3) The antibody was diluted 2-fold starting from 16000 ng / ml, and 15 dilutions were performed. The blank dilution solution was added to the last well as a blank control, 100 μl / well; incubated at 37°C for 1 h;

[0039] (4) Wash the plate three times with detergent and pat dry for later use;

[0040] (5) Add secondary antibody, 100 μl / well; incubate at 37°C for 0.5 h;

[0041] (6) Wash the plate three times with detergent and pat dry for later use;

[0042] (7) Add TMB colorimetric solution, 100 μl / well; incubate at 37°C for 10 min;

[0043] (8) Add stop solution 2M HCl, 50 μl / well;

[0044] (9) Reading, OD450-OD630.

[0045] The test results are shown in Table 1. Figure 2 and Figure 3 shown.

[0046] Table 1: ELISA results of labeled antibodies and coated antibodies

[0047] Antibody concentration (ng / ml) <![CDATA[OD450 标记抗体 ]]> <![CDATA[OD450 包被抗体 ]]> 16000 3.33 3.20 8000 3.22 3.14 4000 3.10 3.09 2000 3.08 3.02 1000 3.03 2.96 500 2.98 2.93 250 2.79 2.88 125 2.50 2.60 62.5 2.02 2.26 31.25 1.49 1.66 15.625 0.95 1.16 7.8125 0.62 0.75 3.90625 0.36 0.44 1.953125 0.20 0.25 0.9765625 0.11 0.12 0 0.02 0.03

[0048] Origin8.0 software can be used to fit the four-parameter fitting curves of two antibody ELISA tests, such as Figure 2 He Ru Figure 3 , Figure 2 and Figure 3 The curves in the figure are all standard S-shaped curves. The affinity KD values ​​of the labeled antibody and the coated antibody are obtained to be 34.2 ng / ml and 28.5 ng / ml, respectively. The two antibodies have good affinity for the corresponding polypeptide antigens.

[0049] 2. Performance verification data

[0050] 2.1 Comparison experiment of sample matching rate

[0051] (1) Detection method:

[0052] Sample processing method: The test samples can be serum, plasma, or whole blood. For serum or plasma, please test within 4 hours after separation. If it cannot be tested within 4 hours, please store it at 2°C-8°C within 5 days; whole blood samples are collected according to conventional methods and should be used as soon as possible after collection. EDTA or sodium heparin can be used to anticoagulate whole blood;

[0053] Reagent card preparation: restore the test strip to room temperature (15℃~30℃) before use, and the test should be performed at room temperature. Open the package and place it on a level, dry surface. Use it as soon as possible within 1 hour after opening to prevent the test card from getting damp.

[0054] Sample testing: restore the sample to room temperature, mix the serum and plasma samples, and then add 4 drops (about 100μL) to the sample well with a dropper; add 4 drops of whole blood sample with a dropper, then add a drop of whole blood buffer to the sample well, wait for 15-20 minutes to observe the results, and the test results will be invalid after more than 30 minutes.

[0055] Result determination: Positive (+): Two purple-red bands appear. One is located in the test area (T) and the other is located in the quality control area (C), which is judged as positive. Negative (-): Only one purple-red band appears in the quality control area (C), and no purple-red band appears in the test area (T), which is judged as negative. Invalid: No purple-red band appears in the quality control area (C), indicating incorrect operation process or reagent deterioration and damage.

[0056] (2) Sample compliance rate evaluation: 200 blood samples of cattle and 200 blood samples of sheep were collected from the ranch 28 days after mating. The colloidal gold trial card of the present invention, the cattle early pregnancy test paper detection card of Beijing Beite Shuang Company, and the sheep early pregnancy rapid detection card of Maikodusi Biological Company were used to detect the obtained serum, plasma, and whole blood samples, and the compliance rate of the colloidal gold reagent card of the present invention and the reagent card of the competitor was calculated.

[0057] Table 2 shows the calculation method of the coincidence rate between two detection methods (specifically, colloidal gold test strips or fluorescent test strips and commercial colloidal gold reagent cards in this application).

[0058] Table 2. Calculation of the compliance rate between the test paper card of the present invention and the commercial colloidal gold reagent card

[0059]

[0060]

[0061] Among them, "a" indicates the number of samples whose test results of both the reagent card of the present invention and the commercial colloidal gold reagent card are positive; "b" indicates the number of samples whose test results of the reagent card of the present invention are negative and the test results of the commercial reagent card are positive; "c" indicates the number of samples whose test results of the reagent card of the present invention are positive and the test results of the commercial reagent card are negative; "d" indicates the number of samples whose test results of both the reagent card of the present invention and the commercial colloidal gold reagent card are negative.

[0062] Table 3 lists the conformity rates between the colloidal gold reagent card of the present invention and the commercial colloidal gold detection reagent card for early pregnancy in cattle. It can be seen from Table 3 that the colloidal gold reagent card of the present invention has a positive conformity rate of up to 98%, a negative conformity rate of up to 96%, and an overall sample conformity rate of up to 97.5% compared with the commercial colloidal gold reagent card.

[0063] Table 3. The conformity rate between the colloidal gold reagent card of the present invention and the commercial colloidal gold detection reagent card for early pregnancy in cattle

[0064]

[0065] Table 4 lists the conformity rates between the colloidal gold reagent card of the present invention and the commercial colloidal gold detection reagent card for early pregnancy in sheep. It can be seen from Table 4 that, compared with the commercial colloidal gold reagent card, the colloidal gold reagent card of the present invention has a positive conformity rate of up to 98.5%, a negative conformity rate of up to 95.5%, and an overall sample conformity rate of up to 97.5%.

[0066] Table 4. The conformity rate between the colloidal gold reagent card of the present invention and the commercial sheep early pregnancy colloidal gold detection reagent card

[0067]

[0068]

Claims

1. A polypeptide antigen of cattle and sheep pregnancy-related glycoprotein, characterized in that: The invention comprises two common antigen polypeptides for bovine and ovine pregnancy-related glycoproteins, and the amino acid sequences thereof are shown as SEQ ID No. 1 and 2 respectively.